Funded Tech Companies
Delix Therapeutics
Based in Boston, Delix Therapeutics has funding from Johnson & Johnson Development Corporation, private investors and re.Mind Capital.
Company Overview
Company Name
Delix Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Boston, MA 02139
USA
Boston, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Based on the discovery of a novel class of neuroplasticity-promoting therapeutics known as psychoplastogens, we are building a world class CNS company on a mission to broaden patient access to safe, fast-acting, and long-lasting medicines for many of the leading causes of disability worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/18/2026
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Rus
Chief Medical Officer
Bigs Robertson
Chief Operating Officer
David Olson
Chief Scientific Officer
Kurt Rasmussen
Company Investors
- Johnson & Johnson Development Corporation
- re.Mind Capital
- Saya Bio
- Negev Capital
- Vertical Venture Partners
- PsyMed Ventures
- Palo Santo
- ARTIS Ventures (Vasudev Bailey)
- Noetic Fund
- WPSS Investments
- Casa Verde Capital
- RA Capital (Andrew Levin)
- Bail Capital
- OMX Ventures
- Presight Capital
- Apeiron Holdings
- R2 Ventures
- Ocama Partners
- Dolby Family Ventures
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs